Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Stomach Neoplasms × Radiofrequency Ablation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 31 Neoplasm Metastasis 12 Liver Neoplasms 9 Colorectal Neoplasms 9 Cholangiocarcinoma 9 Lung Neoplasms 8 Pancreatic Neoplasms 7 Breast Neoplasms 7 Thyroid Nodule 6 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Recurrence 5 Thyroid Neoplasms 4 Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Renal Cell 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain 3 Barrett Esophagus 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Kidney Neoplasms 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2 Bile Duct Neoplasms 2 Adrenocortical Adenoma 2

Interventions

Oxaliplatin 182 Capecitabine 107 Fluorouracil 97 S 1 (combination) 96 Docetaxel 93 Cisplatin 78 Leucovorin 71 Paclitaxel 67 Irinotecan 64 apatinib 42 Drug Therapy 39 sintilimab 35 Surgical Procedures, Operative 34 Hyperthermic Intraperitoneal Chemotherapy 31 Radiotherapy 30 pembrolizumab 28 Trastuzumab 27 Gastrectomy 21 Tegafur 20 Epirubicin 20 XELOX 19 Nivolumab 19 Bevacizumab 19 camrelizumab 17 titanium silicide 16 tislelizumab 16 Ramucirumab 16 Carboplatin 16 Cetuximab 13 Albumin-Bound Paclitaxel 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04574245 2022-10-05

RECORD

Chinese PLA General Hospital

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡